Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study

द्वारा Richardson, Paul G., Chanan-Khan, Asher A., Alsina, Melissa, Albitar, Maher, Berman, David, Messina, Marianne, Mitsiades, Constantine S., Anderson, Kenneth C.
प्रकाशित 2010

Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma

द्वारा Richardson, Paul G., Badros, Ashraf Z., Jagannath, Sundar, Tarantolo, Stefano, Wolf, Jeffrey L., Albitar, Maher, Berman, David, Messina, Marianne, Anderson, Kenneth C.
प्रकाशित 2010

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

द्वारा Revicki Dennis A, van den Eertwegh Alfons JM, Lorigan Paul, Lebbe Celeste, Linette Gerald, Ottensmeier Christian H, Safikhani Shima, Messina Marianne, Hoos Axel, Wagner Samuel, Kotapati Srividya
प्रकाशित 2012-06-01

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

द्वारा Revicki, Dennis A, van den Eertwegh, Alfons JM, Lorigan, Paul, Lebbe, Celeste, Linette, Gerald, Ottensmeier, Christian H, Safikhani, Shima, Messina, Marianne, Hoos, Axel, Wagner, Samuel, Kotapati, Srividya
प्रकाशित 2012

Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors

द्वारा Kunz, Pamela L., He, Aiwu R., Colevas, A. Dimitrios, Pishvaian, Michael J., Hwang, Jimmy J., Clemens, Pamela L., Messina, Marianne, Kaleta, Remigiusz, Abrahao, Fernanda, Sikic, Branimir I., Marshall, John L.
प्रकाशित 2012